SARS-CoV-2 does not infect pigs, but this has to be verified regularly

Tanja Opriessnig1,2, Yao-Wei Huang3

  • 1The Roslin Institute and The Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, UK.

Xenotransplantation
|August 30, 2022
PubMed

Insights

Pigs are currently considered a low risk for SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection, posing no immediate threat to xenotransplantation. Continuous monitoring of new virus variants is crucial for future safety assessments.

Area of Science:

  • Veterinary Virology
  • Infectious Diseases
  • Transplantation Science

Background:

  • The global emergence of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) necessitates evaluating potential zoonotic risks.
  • Xenotransplantation success hinges on donor animals being free from pathogens transmissible to humans.
  • Pigs are a primary species for xenotransplantation, making their susceptibility to SARS-CoV-2 a critical research area.

Purpose of the Study:

  • To review current research on the susceptibility of pigs to SARS-CoV-2.
  • To assess the potential risk of SARS-CoV-2 transmission from pigs to humans.
  • To evaluate the implications of porcine SARS-CoV-2 infection for xenotransplantation.

Main Methods:

  • Literature review of experimental and observational studies on pigs and SARS-CoV-2.
  • Analysis of viral shedding, transmission dynamics, and serological data in pigs.
  • Assessment of risk factors and potential for human-to-pig and pig-to-human transmission.

Main Results:

  • Pigs appear to be susceptible to SARS-CoV-2 infection but generally exhibit mild or subclinical disease.
  • Evidence suggests limited efficient transmission between pigs and humans, with pigs posing a low risk.
  • Current SARS-CoV-2 variants do not appear to pose a significant threat to pigs or xenotransplantation.

Conclusions:

  • Pigs are currently considered a low-risk species regarding SARS-CoV-2.
  • There is no immediate risk to the human population or xenotransplantation recipients from porcine SARS-CoV-2.
  • Ongoing surveillance of emerging SARS-CoV-2 variants is essential to proactively manage potential future risks.